qx-314 has been researched along with cyclic gmp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eysel, UT; Imbrosci, B; Koesling, D; Mergia, E; Mittmann, T; Neitz, A; Petrasch-Parwez, E | 1 |
| Akaike, N; Maeda, M; Mizuno, Y; Nonaka, K; Shin, MC; Shoudai, K; Wakita, M; Yamaga, T | 1 |
2 other study(ies) available for qx-314 and cyclic gmp
| Article | Year |
|---|---|
Postsynaptic NO/cGMP increases NMDA receptor currents via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.
Topics: Anesthetics, Local; Animals; Animals, Newborn; CA1 Region, Hippocampal; Cyclic GMP; Electric Stimulation; Excitatory Amino Acid Antagonists; Guanylate Cyclase; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; In Vitro Techniques; Lidocaine; Long-Term Potentiation; Mice; Mice, Knockout; Neurons; Nitric Oxide; Patch-Clamp Techniques; Pyrimidines; Receptors, N-Methyl-D-Aspartate; Tetraethylammonium | 2014 |
Potent and direct presynaptic modulation of glycinergic transmission in rat spinal neurons by atrial natriuretic peptide.
Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Anesthetics, Local; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cyclic GMP; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glycine; Hippocampus; Inhibitory Postsynaptic Potentials; Lidocaine; Neurons; Peptides, Cyclic; Potassium Channel Blockers; Presynaptic Terminals; Rats; Rats, Wistar; Spinal Cord; Thionucleotides | 2013 |